Yuichiro Kikawa, Breast oncologist at Kansai Medical University, shared a post on X:
“Korea NHIS breast cancer: ~12% of rural patients traveled to Seoul.
Travelers were younger/healthier, treated at tertiary centers, but had longer waits.
Survival improved overall vs rural care (HR ~0.75); no clear benefit when initial treatment was chemotherapy. Avoid >30-day delays.”
More posts about ESMO Asia 2025.